Application of H4 agonist in the treatment of idiopathic pulmonary fibrosis

摘要

The present invention relates to the use of histamine agonist molecule H4, amino-7-trihydroxy-4,5,6-oxo-1-dihydro-1,3-isobenzofuran-3) 1-1-methoxy-8-methyl-2-methyldioxo-6,7-tetrahydro -, 2,3,4-quinoline or trihydroquinoline for the treatment of pulmonary fibrosis.